LENZ Therapeutics’ Presbyopia Treatment VIZZ Receives FDA Approval in the U.S.
PharmExec
AUGUST 1, 2025
August 1st 2025 FDA Mandates Safety Alterations to Opioid Pain Medication Labels Nicholas Jacobus FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain management.
Let's personalize your content